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Enterovirus D68 (EV-D68) is an emerging pathogen that recently caused a large outbreak
of severe respiratory disease in the United States and other countries. Little is known
about the relationship between EV-D68 virus and host cells. In this study, we assessed
the effect of the host cell cycle on EV-D68 viral production, as well as the ability of EV-D68
to manipulate host cell cycle progression. The results suggest that synchronization in
G0/G1 phase, but not S phase, promotes viral production, while synchronization in
G2/M inhibits viral production. Both an early EV-D68 isolate and currently circulating
strains of EV-D68 can manipulate the host cell cycle to arrest cells in the G0/G1 phase,
thus providing favorable conditions for virus production. Cell cycle regulation by EV-D68
was associated with corresponding effects on the expression of cyclins and CDKs,
which were observed at the level of the protein and/or mRNA. Furthermore, the viral
non-structural protein 3D of EV-D68 prevents progression from G0/G1 to S. Interestingly,
another member of the Picornaviridae family, EV-A71, differs from EV-D68 in that G0/G1
synchronization inhibits, rather than promotes, EV-A71 viral replication. However, these
viruses are similar in that G2/M synchronization inhibits the production and activity of both
viruses, which is suggestive of a common therapeutic target for both types of enterovirus.
These results further clarify the pathogenic mechanisms of enteroviruses and provide a
potential strategy for the treatment and prevention of EV-D68-related disease.
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INTRODUCTION
Human enterovirus 68 (EV-D68) is an emerging pathogen that can cause severe respiratory disease
and is associated with cases of paralysis, especially among children. It was first isolated from
samples obtained in California in 1962 from four children with pneumonia and bronchiolitis
(Schieble et al., 1967). Over the past 10 years, EV-D68 infection outbreaks have been reported in
Italy, the United States, Germany, China, and several other countries (Esposito et al., 2015; Farrell
et al., 2015; Reiche et al., 2015; Zhang et al., 2015), with a record number of confirmed cases in
2014 (http://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html). Unfortunately, no vaccines
for prevention or medicines for treatment are currently available for future outbreaks, mainly due
to the fact that information on host factors required for EV-D68 replication is scarce.
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EV-D68 belong to enterovirus (family Picornaviridae, genus
Enterovirus), which are non-enveloped, positive-sense single-
strand RNA viruses of approximately 7500 nt and contain a large
open reading frame that encodes a polyprotein that is cleaved to
yield corresponding viral proteins. Based on the molecular and
biological characteristics, four human enterovirus (HEV) species
are currently designated as HEV-A, -B, -C, and -D (Oberste
et al., 1999a,b). The representative of HEV-A serotype is human
enterovirus 71 (EV-A71), which is a primary causative agent
for Hand, foot, and mouth disease (HFMD) that is associated
with the recent outbreaks in Asia (Liu et al., 2011; Wang et al.,
2012). EV-D68 is assigned to HEV-D serotype, but EV-D68 is
unlike other enteroviruses in that it is acid labile and biologically
more similar to human rhinoviruses that are associated with
respiratory diseases (Smura et al., 2010).
As a feature of their pathogenic mechanism, many viruses
facilitate their own replication by interacting with host factors
that regulate cell cycle progression. Examples can be discovered
in DNA viruses, retroviruses and RNA viruses. DNA viruses,
which replicate in the nucleus, have been extensively investigated
in regard to control the cell cycle of host cells. For example,
some small DNA viruses including simian virus 40 (DeCaprio
et al., 1988), adenovirus (Howe et al., 1990; Eckner et al., 1994),
and human papillomavirus (Werness et al., 1990), which lack
their own polymerases, use the host polymerase to promote
the entry of cells into S phase from G0/G1 phase. For other
large DNA viruses, for example, herpesviruses can induce G0/G1
arrest in order to avoid competing for cellular DNA replication
resources (Flemington, 2001). Cell cycle regulation also has been
observed for retroviruses, which, like DNA viruses, replicate in
the nucleus. The Vpr protein of human immunodeficiency virus
type 1 is responsible for eliciting cell cycle arrest in G2/M phase
(He et al., 1995; Goh et al., 1998). Furthermore, RNA viruses,
whose primary site of replication is normally the cytoplasm,
have also been demonstrated to interfere with the host cell cycle.
Infectious bronchitis virus (IBV) induces an S and G2/M-phase
arrest to favor viral replication (Dove et al., 2006; Li et al.,
2007), and mouse hepatitis virus (MHV) (Chen and Makino,
2004) and some severe acute respiratory syndrome coronavirus
(SARS-CoV) proteins induce cell cycle arrest in G0/G1 phase
(Yuan et al., 2005, 2006). In a previous study, we found that
human EV-A71 and Coxsackievirus A16, manipulate the host cell
cycle at S phase in order to promote their own viral replication
(Yu et al., 2015); however, the potential manipulation of the
host cell cycle by EV-D68, which is associated with higher
lethality in recent large-scale outbreaks, has not been previously
characterized.
In the current study, we examined the effects of the
cell cycle status on EV-D68 viral replication, as well as
the impact of EV-D68 virus on the host cell cycle. Our
data show that EV-D68 replication is integrally associated
with the host cell cycle, though the pattern of regulation
differs distinctly from that of EV-A71. These results
further increase the understanding of the pathogenic
mechanisms of enteroviruses and provide a potential target
for the treatment and prevention of enterovirus-related
diseases.
MATERIALS AND METHODS
Viruses and Cells
The Fermon (ATCC, VR-1826), US/KY/14-18953 (ATCC, VR-
1825D), and US/MO/14-18947 (ATCC, VR-1823D) strains of
EV-D68; and the Changchun077 strain of EV-A71 have been
reported previously (Wang et al., 2012). Viruses were propagated
in human rhabdomyosarcoma RD cells (No CCL-136), and
the supernatants were harvested and stored at −80◦C. Human
embryonic kidney cells (HEK 293T cells) (No CRL-11268) and
RD cells were purchased from the ATCC (Manassas, VA, USA)
and used according to a previous study (Wang et al., 2015).
Cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM) (Hyclone, Logan, UT, USA) supplemented with 10%
fetal bovine serum (FBS) (GIBCO BRL, Grand Island, NY, USA).
Viral Titer Determination
The viral titers were determined by measuring the 50% tissue
culture infective dose (TCID50) in a microtitration assay using
RD cells, as described (Gay et al., 2006). RD cells were seeded
and incubated at 37◦C for 24 h in 96-well plates. Virus-
containing supernatant was serially diluted 10-fold, and 100µl
of diluent virus was added per well in octuplicate. Until
the experimental endpoint was reached the cytopathic effect
was observed once per day. According to the Reed-Muench
method (Reed, 1983) the viral titers of the TCID50 were
determined, based on the assumption that material with 1 ×
105 TCID50/ml will produce 0.7 × 105 plaque forming units/ml
(www.protocol-online.org/biology-forums/posts/1664.html).
Infection
Cells were mock-infected or infected with EV-D68 or EV-A71
at a multiplicity of infection (MOI) of 0.8. After 2 h of virus
adsorption, cells were washed with phosphate-buffered saline
(PBS) one time, then added fresh culture medium.
Cell Cycle Release
Subconfluent cultures of RD cells were synchronized in G0/G1
phase by serum deprivation (He et al., 2010). Approximately 5×
105 cells were plated in a 6-well plate and maintained in serum-
free medium for 24 h. After EV-D68 virus infection, fresh 10%
DMEM was added to release the cells from G0/G1.
Synchronization of Cells
In order to observe the effects of the cell cycle on virus growth,
subconfluent cultures of RD cells were synchronized in G0/G1
phase by serum deprivation for 24 h (He et al., 2010). For S-phase
synchronization, a final concentration of 0.85mM thymidine
(Sigma) were added (Helt and Harris, 2005; Yu et al., 2015) for
24 h. For G2/M synchronization, 25 ng/ml of nocodazole (Sigma)
was added (He et al., 1995; Yu et al., 2015) for 24 h. For sustained
S and G2/M cell-cycle arrest after virus infection, cells were
treated with fresh 0.85mM thymidine and 25 ng/ml nocodazole
for the indicated times.
Cell Cycle Analysis by Flow Cytometry
Propidium iodide (PI) staining was used to measure the
nuclear DNA content according to previous study (Yu et al.,
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2015). Firstly, the cells were collected and fixed with 1ml of
cold 70% ethanol at 4◦C overnight and then re-suspended
in PI staining buffer (50µg/ml PI (Sigma), 20µg/ml RNase
in PBS) for 2 h at 4◦C. Fluorescence-activated cell sorting
(FACScan; BD) were used to analyze the PI-stained cells, and
at least 10,000 cells were counted for each sample. ModFit LT,
version 2.0 (Verity Software House) was performed for data
analysis.
Western Blot Analysis
Virus-infected or mock-infected cells were collected at
various times after EV-D68 infection and washed once
with PBS as previously described (Yu et al.). The following
antibodies were used in Western blot analyses: anti-CDK2
(Cell Signal), anti-cyclinE1 (Proteintech), anti-CDK4
(Cell Signal), anti-CDK6 (Cell Signal), anti-cyclinD (Cell
Signal), anti-CDK1 (Boster), anti-cyclinB1 (Santa Cruz),
and anti-histone (GenScript). Secondary antibodies from
mouse or rabbit were obtained from Jackson Immuno
Research.
Quantitative Real-Time PCR
All work was carried out in a designated PCR-clean area
as previously described (Yu et al.). RNA was extracted from
infected and uninfected cells using Trizol reagent (Gibco-BRL,
Rockville, Md.) and isolated as specified by the manufacturer.
The RNA was DNAse-treated (DNase I-RNase-Free, Ambion)
to remove any contaminating DNA; 200 ng of total RNA
was reverse-transcribed with oligo dT primers using the High
Capacity cDNA RT Kit (Applied Biosystems) in a 20 µl cDNA
reaction, as specified by the manufacturer. For quantitative
PCR, the template cDNA was added to a 20 µl reaction
with SYBR GREEN PCR Master Mix (Applied Biosystems)
and 0.2 µM of primer (Table 1). The amplification was
carried out using an ABI Prism 7000 for 40 cycles under the
following conditions: initial denaturation at 95◦C for 10min;
40 cycles of 95◦C for 15 s and 60◦C for 1min. The fold
changes were calculated relative to GAPDH using the 11Ct
method.
Enzyme-Linked Immunosorbent Assays
The cell lysates were examined for CDK4, CDK6, cyclinD1,
CDK2, cyclinE1, CDK1, cyclinB1 and histone with ELISA kits
(Meiyan, Shanghai, China) according to the manufacturer’s
instructions. The microplate was quantified using a microplate
reader (Bio-Rad, Hercules, CA, USA). Target protein expression
was normalized to the histone expression.
Statistical Analyses
Statistical differences were analyzed using the Student’s
t-test for all analysis, except of 3C and 3D dose-dependent
test in Figures 4B,D with Pearson correlation coefficient.
Data are presented as means and standard deviations
(SD). ∗P-values of < 0.05 were considered statistically
significant. TA
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RESULTS
Synchronization at Different Cell Cycle
Stages Has Profound Effects on EV-D68
Production
Viral replication often is integrally associated with the cell cycle
status of host cells (Feuer et al., 2002). To explore the possible
benefits of different cell cycle phases for EV-D68 viral replication,
we synchronized cells in different phases and then assessed
viral replication and virulence. First, we assessed the effects of
G0/G1 synchronization by serum deprivation (Darzynkiewicz
et al., 1980). RD cells were cultured in either serum medium
(control) or serum-free medium (G0/G1 synchronization) for
24 h. Then the cells were infected with the same titer of 0.8
MOI of EV-D68 (Fermon strain) or were mock-infected for
2 h, and either serum medium or serum-free medium was
added for another 24 h (Figure 1A). As previously reported (He
et al., 2010), serum deprivation induced obvious G0/G1 arrest
as assessed by flow cytometry (P < 0.001; Figure 1B). At 2 h
post-infection (viral entry stage), the EV-D68 genomic RNA
levels were not significantly different in the control and serum-
starved cells (Figure 1M); however, at 18 h post infection (viral
replication stage) 13.55 times more viral RNA was detected in
the serum-starved cells than in the control cells (P < 0.01;
Figure 1C). Furthermore, at 24 h (viral production stage) the
TCID50/mL of infectious EV-D68 particles was 348.84 times
higher for supernatant from G0/G1 phase-synchronized cells
(202.17 ± 42.60 × 105) than for supernatant from control cells
(0.59 ± 0.08 × 105) (P < 0.01; Figure 1D). These results suggest
that G0/G1-phase arrest does not affect viral entry, but promotes
EV-D68 viral replication and production.
To determine whether viral replication and production also
is elevated at other phases of the cell cycle, the effect of S
phase synchronization was assessed. The cells were cultured in
medium or were synchronized in S phase by culture with 0.85
mM thymidine for 24 h. Then, the cells were mock infected or
were infected with 0.8 MOI of EV-D68 for 2 h, and fresh culture
medium or 0.85 mM thymidine was added for another 24 h
(Figure 1E). Thymidine induced obvious S phase arrest (P <
0.001; Figure 1F). The genomic RNA level remained similar in
S phase-synchronized cells and control non-synchronized cells
at 2 h post-infection (Figure 1M) and at 24 h post-infection (P
> 0.05; Figure 1G). Furthermore, the TCID50/mL values at 24 h
post-infection were equivalent for the S phase-synchronized cell
supernatant (2.59± 1.37× 105) and the control cell supernatant
(3.28 ± 1.80 × 105) (P > 0.05; Figure 1H). These results suggest
that S-phase arrest does not affect EV-D68 viral entry, replication
or production.
To assess the effects of G2/M phase synchronization, cells were
cultured in medium or were treated with 25 ng/ml nocodazole
for 24 h; then, the cells were mock infected or were infected with
EV-D68 at 0.8 MOI for 2 h, and cultured in fresh medium or
25 ng/ml nocodazole for another 24 h (Figure 1I). Nododazole
induced obvious G2/M arrest (P < 0.001; Figure 1J). At 2 h
post-infection, there was no significant difference in the genomic
RNA level in the control and G2/M phase-synchronized cells
(Figure 1M); however, at 24 h post-infection the genomic level
was lower in the synchronized cells than in the control cells
(P < 0.05; Figure 1K). Furthermore, at 24 h post-infection the
TCID50/mL for supernatant from the G2/M phase-synchronized
cells (0.46 ± 0.29 × 105) was obviously lower than that from
the control cells (1.40 ± 0.16 × 105) (P < 0.01; Figure 1L).
Therefore, these results suggest that G2/M synchronization does
not affect viral entry, but inhibits EV-D68 viral replication and
production.
EV-D68 Infection Manipulates the Host Cell
Cycle and Arrests Cells at G0/G1
Given that EV-D68 replication and production is dependent
on the cell cycle, we next asked whether EV-D68 might have
the ability to manipulate the host cell cycle to facilitate its
own production. RD cells were infected with EV-D68 Fermon
stain at an MOI of 0.8, and the cells were collected for cell
cycle distribution analysis after 24 h. An obvious increase in the
percentage of cells in G0/G1 was observed in EV-D68-infected
cells (45.20 ± 0.14%) as compared to mock-infected cells (36.50
± 0.76%) (23.84% increase; P < 0.01; Figure 2A). Therefore,
EV-D68 itself can manipulate the host cell to accumulate
preferentially at G0/G1 phase rather than at G2/M, which favors
viral production.
Though the latter experiments were performed using the
Fermon strain of EV-D68, which was isolated from 4 children
with pneumonia and bronchiolitis in the United States in 1962
(Schieble et al., 1967; Zhang et al., 2015), several more recent
strains of the virus have been isolated. The currently circulating
EV-D68 US/MO/14-18947 and US/KY/14-18953 strains are
similar to the Fermon strain in clinical characteristics and
genome structure, but it is not known whether they are similar
in virulence and ability to manipulate the cell cycle. Therefore,
we compared the US/MO/14-18947 and US/KY/14-18953 strains
to the Fermon strain. Under normal culture conditions, RD
cells were infected with three strains virus at an MOI of 0.8
for 24 h, respectively, the TCID50/mL of the US/MO/14-18947
strain (43.07 ± 10.22 × 105) was 29.76 times higher and the
TCID50/mL of the US/KY/14-18953 (195.00 ± 54.03 × 105)
was 138.29 higher than the TCID50/mL of the Fermon strain
(1.40 ± 0.16 × 105) (Figure 2B). These results suggest that the
EV-D68 virulence has increased over time, which could explain
the recent rise in the incidence of Enterovirus-related disease
(Esposito et al., 2015; Farrell et al., 2015; Reiche et al., 2015; Zhang
et al., 2015).
Next, we assessed the cell cycle distribution after RD cells
were infected with the currently circulating strains of EV-D68 at
an MOI of 0.8 for 24 h. An obvious increase in the percentage
of cells in G0/G1 phase was observed for both US/MO/14-
18947 (25.83% increase; P < 0.01) (Figure 2C) and US/KY/14-
18953 (10.85% increase; P < 0.01) (Figure 2D). These strains
also caused a corresponding increase in the ratio of cells in
G0/G1–G2/M (53.54% increase for US/MO/14-18947; 85.91%
increase US/KY/14-18953; P < 0.001; Figures 2C,D). Therefore,
the currently circulating strains possess increased virulence and a
similar ability as the Fermon strain to skew the cell cycle toward
the G0/G1 phase, which facilitates viral production.
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FIGURE 1 | Different cell cycle stages have profound effects on EV-D68 replication. The effects of cell cycle synchronization on EV-D68 are shown for G0/G1
arrest (A–D), S phase arrest (E–H), and G2/M arrest (I–L). (A,E,I) Flow diagram of how RD cells were treated with serum starvation (starved) for G0/G1
synchronization (A), with thymidine (thymi) for S synchronization (E), or with nocodazole (noco) for G2/M synchronization (I). The top diagram in each panel shows the
strategy for the control group, and the bottom panel shows the strategy for cell cycle synchronization. (B,F,J) Cell-cycle profiles were determined by flow cytometry
after G0/G1, S, and G2/M synchronization with serum starvation, thymidine, and nocodazole treatment, respectively. Histograms below show the percentage of cells
in each phase of the cell cycle as analyzed by the ModFit LT program. (C,G,K) Levels of intracellular EV-D68 Fermon strain RNA were detected in RD cells after cell
cycle synchronization by quantitative real-time PCR. The results were standardized to GAPDH mRNA expression and normalized to 1.0 in mock-infected cells. (D,H,I)
Progeny viruses in the supernatants were titrated using RD cells. A relative quantitative analysis of the TCID50/mL is shown. (M) Intracellular EV-D68 Fermon strain
RNA levels were detected in RD cells with different cell cycle synchronization treatment by quantitative real-time PCR at post-infection 2 h. The results were
standardized using GAPDH mRNA as a control and normalized to 1.0 in mock-infected cells. The results represent the mean ± S.D of three independent experiments.
*P < 0.05, **P < 0.01, and ***P < 0.001.
EV-D68 Infection Inhibits G0/G1 Exit
To further understand the mechanism of EV-D68 manipulation
of the host cell cycle, we assessed whether EV-D68 could
regulate cell cycle exit from G0/G1 into S phase. RD cells
were synchronized in G0/G1 by serum starvation for 24 h, and
then mock-infected or infected with EV-D68 Fermon strain for
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FIGURE 2 | EV-D68 infection induces G0/G1 arrest. (A,C,D) RD cells were infected with EV-D68 Fermon (A), US/MO/14-18947 (C) or US/KY/14-18953 (D) at an
MOI of 0.8 or mock for 24 h for analysis of cell cycle status. Left: Cell-cycle profiles were determined by flow cytometry. Middle: The histograms show the percentage
of cells in each phase of the cell cycle in mock-infected and EV-D68-infected cells. Right: The ratio of G0/G1 to G2/M is shown. (B) The virulence of Fermon,
US/KY/14-18953 and US/MO/14-18947strains in infected RD cells was assessed 24 h post-infection with virus at MOI 0.8. Values are expressed as the TCID50/mL
of the progeny viruses in the supernatant. The results represent the mean ± S.D of three independent experiments. **P < 0.01 and ***P < 0.001.
2 h. The cells were then stimulated with 10% FBS in order to
trigger cell cycle re-entry into S phase from G0/G1. At 24 h
of mitogenic stimulation with serum, the mock-infected cells
progressed synchronously from G0/G1 into S phase. In contrast,
the majority of the EV-D68-infected RD cells remained in G0/G1
phase over the 24 h time period without S entry (P < 0.001;
Figure 3A). Therefore, these results support a model in which
EV-D68 infection regulates the cell cycle by preventing entry into
the S phase.
Cyclin/CDK complexes are known to regulate cell cycle
progression (Sherr, 1994). To identify the key molecules and
signaling pathways that may mediate the inhibition of cell entry
into S phase by EV-D68, we examined the protein expression
profiles of host G0/G1-phase and S-phase proteins by Western
blotting of RD cells at 0, 16, 20, 24, and 28 h post-infection.
Among themolecules CDK4, CDK6, and cyclinD (whichmediate
cell cycle progression in G0/G1; Massagué, 2004) and CDK2
and cyclinE1 (which mediate cell cycle transition from G0/G1
to S phase; Hinds et al., 1992), the expression of CDK6 was not
changed, and the expression of cyclinE1 was increased at 24 h
post-infecion (Figure 3B), while all of them were significantly
decreased in virus-infected cells as compared to mock-infected
cells at 28 h post-infection (Figures 3B,G). Furthermore, the
CDK2mRNA level was decreased by EV-D68 infection; however,
there were no significant differences between the virus andmock-
infected groups in CDK4, CDK6, cyclinD or cyclinE1 mRNA
levels (Figure 3C). Therefore, EV-D68 infection inhibits host
expression of several cell cycle proteins, which is consistent
with its ability to inhibit G0/G1 to S phase entry, and the
modulation is likely to occur transcriptionally for CDK2 and
post-transcriptionally for CDK4, CDK6, cyclinD, and cyclinE1.
EV-D68 Infection Promotes G0/G1 Entry
To further examine the potential effect of virus infection on cell
cycle transition from G2/M phase into G0/G1, RD cells were
treated with 25 ng/ml nocodazole or medium for 24 h for G2/M
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 6 February 2017 | Volume 7 | Article 29
Wang et al. Cell Cycle and Viral Replicaiton
phase synchronization and then the cells were mock infected or
infected with EV-D68 at 0.8 MOI for 2 h. Next, the cells were
treated for an additional 24 h with 25 ng/ml nocodazole or fresh
medium. Nocodazole induced obvious G2/M cell cycle arrest
(35.91± 1.44 vs. 18.77± 0.20%; P< 0.01); however, after EV-D68
infection for 24 h, the percentage of cells in G2/M was decreased
(21.82 ± 1.07 vs. 35.91 ± 1.44; P < 0.001), and the percentage
of cells in G0/G1 was increased (48.59 ± 1.22 vs. 32.51 ± 0.21; P
< 0.01) (Figure 3D). Therefore, EV-D68 infection also regulates
the cell cycle by promoting exit from G2/M phase. Consistent
with these findings, the expression of cyclinB1 and CDK1 (which
mediate G2/M progression; Coverley et al., 2002; Yam et al.,
2002) was down regulated by EV-D68 infection (Figures 3E,G).
CDK1 was decreased at the mRNA level upon EV-D68 infection
(transition fromP < 0.01), but cyclinB1 mRNA expression was
not significantly regulated (Figure 3F). Therefore, EV-D68 virus
promotes cell cycle exit from G2/M and entry into G0/G1 by
modifying the pathway of G0/G1 entry at the transcriptional level
for CDK1 and at the post-translational level for cyclinB1.
The Non-structural Proteins 3D and 3C of
EV-D68 Mediate Cell Cycle Alterations
A previous study concluded that exogenous expression of EV-
A71 viral non-structural 3D protein, an RNA-dependent RNA
polymerase, mediates cell cycle arrest at S phase (Yu et al.).
Given this finding, we examined whether non-structural 3D
protein of EV-D68 had the same ability to mediate cell cycle
alteration. Transfection of 3D expression vector (2µg) induced
G0/G1 arrest, with an increase in the percentage of G0/G1
cells from 39.37 ± 0.52% to 44.76 ± 1.29% (13.69% increase;
P < 0.01) and a corresponding increase in the G0/G1–G2/M
ratio from 2.02 ± 0.04 to 2.62 ± 0.18 (29.70% increase; P <
0.01) (Figure 4A). Furthermore, the extent of the increase in
the percentage of G0/G1 cells was dependent on the dose of
3D vector (0, 0.5, 1, 2µg; R = 0.932; P < 0.001), and the
G0/G1 to G2/M ratio also depended on the dose of 3D vector
(R = 0.827; P < 0.001; Figure 4B). These results suggest that
the non-structural protein 3D of EV-D68 contributes to G0/G1
arrest.
FIGURE 3 | Continued
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FIGURE 3 | EV-D68 infection prevents cell exit from G0/G1 into S phase and promotes G2/M to G0/G1 transition. (A) RD cells were serum-starved for 24 h
and then mock-infected (mock) or infected with EV-D68 Fermon strain (infected) at an MOI of 0.8. After 2 h of virus adsorption, the cells were treated with medium
without FBS for 18 h, followed by medium containing 10% FBS. Top panel: The cell cycle profiles were determined by flow cytometry at 0, 18, 24, and 30 h
post-infection. Bottom panel: The histograms show the percentage of cells in each phase of the cell cycle. (B) G0/G1 and S phase-related cell cycle proteins were
analyzed by western blot analysis. RD cells were mock-infected (m) or infected with EV-D68 Fermon strain at an MOI of 0.8 (i) for 0, 16, 20, 24, and 28 h. Histone is
shown as a loading control. Results are representative of three independent experiments. (C) At 24 h post-infection, mRNA levels of CDK2, cyclinE1, CDK4, CDK6,
and cyclinD were evaluated in mock infected (mock) and EV-D68 infected (infected) cells by quantitative real-time PCR. The results are standardized to GAPDH and
normalized to 1.0 in mock-infected cells. (D) RD cells were treated with 25 ng/mL nocodazole or control medium for 24 h, infected with EV-D68 Fermon strain at an
MOI of 0.8 or mock for 2 h and then re-treated with 25 ng/mL nocodazole for synchronization. Top panel: Cell-cycle profiles were determined by flow cytometry. Low
panel: The histograms show the percentage of cells in each phase of the cell cycle. (E) G2/M phase-related proteins were detected by western blot analysis. Results
are representative of three independent experiments. (F) At 24 h post-infection, mRNA levels of CDK1 and cyclinB1 were assessed in mock-infected (mock) and
EV-D68 infected (infected) cells by quantitative real-time PCR. The results are standardized to GAPDH mRNA and normalized to 1.0 in mock-infected cells. (G) At 28 h
post-infection, the protein concentration of CDK4, CDK6, cyclinD1, CDK2, cyclinE1, CDK1, cyclinB1, and histone were assessed in mock-infected (mock) and
EV-D68 infected (infected) cells by Elisa kit. The results are standardized to Histone (his). The results indicate the mean ± S.D of three independent experiments.
*P < 0.05, **P < 0.01, and ***P < 0.001.
We also examined the potential role of non-structural protein
3C in cell cycle regulation by EV-D68. Transfection of high
dose 3C expression vector (2µg) decreased the percentage of
cells in G2/M phase from 19.53 ± 0.26% to 13.19 ± 0.48%
(32.46% decrease) and increased in the ratio of cells in G0/G1
to G2/M from 2.01 ± 0.04 to 2.75 ± 0.17 (36.82% increase; P
< 0.01) (Figure 4C). High dose 3C transfection also increased
the percentage of cells in S phase (from 41.10 ± 0.48% to 50.53
± 0.73%). Although the change in the cell cycle profile was not
dose-dependent, the G0/G1 to G2/M ratio was dose-dependent
(R= 0.951; P < 0.001; Figure 4D). These results suggest that the
non-structural protein 3C may contribute to the enhanced cell
cycle exit from G2/M phase after EV-D68 infection.
To verify these findings and to evaluate the mechanism
of cell cycle regulation after 3D and 3C transfection, we
performed Western blotting assays to examine their effect on the
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FIGURE 4 | The non-structural protein 3D and 3C of EV-D68 mediates cell cycle alterations. (A,C) Effect of 3D and 3C on cell cycle progression. Left panel:
The distribution of cell cycle in 293T cells was analyzed at 36 h after transfection with 2 µg of VR1012-3D-HA (3D), VR1012-3C-HA (3C) or the corresponding control
vector VR1012 (mock). Right panel: The ratio of cells in G0/G1 to G2/M at 36 h after transfection with 2 µg of VR1012-3D-HA (3D), VR1012-3C-HA (3C) or the
corresponding control vector VR1012 (mock). (B,D) The cell cycle distribution in 293T cells was analyzed at 36 h after transfection with 0, 0.5, 1, or 2 µg plasmid as
indicated. Left panel: The histograms show the percentage of each phase in the cell cycle. Right panel: The ratios of cells in G0/G1 to G2/M. (E,F) The expression of
cell cycle-related proteins after transfection of 293T cells with 3D, 3C or corresponding vector (mock) was assessed by Western blot analysis at 36 h. Histone is
shown as a loading control. (G) Model for the distinct effects of the non-structural proteins 3D and 3C in cell cycle arrest caused by EV-D68. The results indicate the
mean ± S.D of three independent experiments. **P < 0.01 and ***P < 0.001.
expression of cycle-related proteins. Consistent with the cell cycle
analyses, 3D down-regulated the expression of cyclinD, CDK4,
CDK2, and cyclinE1 (Figure 4E), while 3C down-regulated
the expression of CDK1 and cyclinB1 (Figure 4F). Therefore
the non-structural protein 3C facilitates exit from G2/M
and the non-structural protein 3D mediates arrest in G0/G1
(Figure 4G).
G0/G1-Phase Synchronization Has Distinct
Effects on EV-D68 and EV-A71 Viral
Replication
EV-D68 (serotype HEV-D) and EV-A71 (serotype HEV-A)
are both enteroviruses. We have demonstrated that
G0/G1 synchronization promotes EV-D68 viral replication
(Figures 1A–D). However, in our previous study, we
determined that G0/G1 synchronization inhibits EV-A71
viral replication. To exclude experimental variation as an
explanation for the disparate responses of these viruses to G0/G1
synchronization, we performed a side-by-side comparison
of the two enteroviruses. Our results confirm that no serum
treatment induces G0/G1 synchronization (Figures 5A,B) and
G0/G1 synchronization has opposite effects for the two viruses
(Figure 5). After 18 h infection with EV-D68, the viral genomic
mRNA level was 13.55 times higher in serum-starved cells
than in control cells (P < 0.01; Figure 5C); however, after 18
h infection with EV-A71, the viral genomic mRNA level was
3.12 times lower in serum-starved cells (P < 0.05; Figure 5D).
Furthermore, after 24 h infection, the TCID50/mL for EVD68
was 341.66 times higher for G0/G1 phase-synchronized cells
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FIGURE 5 | G0/G1-phase synchronization has different effect on the replication of EV-A71 and EV-D68. RD cells infected with EV-D68 Fermon strain (A,C,E)
or EV-A71 (B,D,F) at an MOI of 0.8 and the effects of synchronization by starvation were assessed. (A,B) RD cells were serum-starved for 48 h to synchronize cells in
G0/G1 phase. The cell-cycle distribution was then detected by flow cytometry. The histograms showed the percentage of each phase in the cell cycle. (C,D) At 18 h
post-infection, intracellular EV-D68 and EV-A71 RNA levels were assessed in control medium (con+infected)-treated or no serum (starved+infected)-treated RD cells
by quantitative real-time PCR. The results were standardized using GAPDH mRNA as a control and normalized to 1.0 in mock-infected cells. (E,F) At 24 h
post-infection, The TCID50/mL was shown through titrating the progeny viruses of EV-D68 or EV-A71 in the supernatants with RD cells. The results represent the
mean ± S.D of three independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001.
than for control cells (202.17 ± 42.60 × 105 vs. 0.59 ± 0.08
× 105; P < 0.01; Figure 5E), while the TCID50/mL for EV-
A71 was 489.37 times lower for G0/G1 phase-synchronized
cells than for control cells (0.46 ± 0.15 × 105 vs. 225.11 ±
129.36 × 105; P < 0.05; Figure 5F). These results confirm
that G0/G1-phase arrest has different effects for the two
enteroviruses.
G2/M-Phase Synchronization Has Similar
Effects on Different Strains of EV-D68 and
EV-A71
G2/M synchronization with nocodazole has been shown
to inhibit both the EV-D68 Fermon strain in this study
(Figures 1I–L) and EV-A71 in our previous study (Yu et al.,
2015). To determine whether similar effects of G2/M-phase
synchronization are observed for the currently circulating strains
of EV-D68, cells were treated with 25 ng/ml nocodazole or
medium for 24 h, and were then infected at 0.8 MOI for
2 h and treated with 25 ng/ml nocodazole or fresh medium
for another 24 h. Our results demonstrate that nocodazole
treatment decreased the genomic RNA levels (Figure 6A) and the
TCID50/ml value (Figure 6B) of Fermon, US/KY/14-18953 and
US/MO/14-18947, which suggests that the virus inhibition upon
G2/M synchronization may be similar for all enteroviruses.
To confirm that G2/M synchronization inhibits EV-D68 and
EV-A71, we assessed the effects of an alternate agent that can
exert G2/M arrest in vitro, pseudolaric acid B (PAB), which
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FIGURE 6 | Synchronization in the G2/M phase inhibits the replication of EV-D68 and SV-A71. (A–C) RD cells were treated with or without 25 ng/mL
nocodazole (noco) for 24 h, infected with EV-D68 Fermon (FER), US/MO/14-18947 (MO) or US/KY/14-18953 (KY) strains at an MOI of 0.8 for 2 h, and then treated
again with or without 25 ng/mL nocodazole for synchronization. (A) At 24 h post-infection, intracellular EV-D68 RNA levels were detected by quantitative real-time
PCR. The results were standardized using GAPDH mRNA as a control and normalized to 1.0 in mock-infected cells. (B) At 24 h post-infection, the TCID50/ml of the
(Continued)
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FIGURE 6 | Continued
progeny viruses was determined. (C–G) RD cells were infected with EV-D68 strains US/KY/14-18953 or EV-A71 at an MOI of 0.8 for 2 h, and then treated with 2 µM
Pseudolaric acid B (PAB) for 24 h for G2/M synchronization. (C) RD cells were treated with 2 µM Pseudolaric acid B (PAB) for 24 h for G2/M synchronization. Top
panel: Cell-cycle profiles were determined by flow cytometry. Bottom panel: The histograms show the percentage of cells in each phase of the cell cycle. (D,E)
Intracellular EV-D68 or EV-A71 RNA levels were assessed in control medium (con+infected) or PAB containing medium (PAB+infected)-treated RD cells by real-time
quantitative PCR. The results are standardized by GAPDH mRNA as a control and normalized to 1.0 in control-infected cells. (F,G) The progeny viruses of EV-D68 or
EV-A71 in the supernatant were titrated using RD cells, and the TCID50/mL was shown. The results indicate the mean ± S.D of three independent experiments.
*P < 0.05, **P < 0.01, and ***P < 0.001.
is a diterpene acid isolated from the root and trunk bark
of Pseudolarix kaempferi Grord (Pinaceae) (Yu et al., 2007,
2013). PAB was confirmed to promote G2/M arrest after 24 h
(Figure 6C). To assess the effects of PAB on viral RNA and
virulence, RD cells were infected with EV-D68 US/KY/14-18953
strain or EV-A71 at an MOI of 0.8 for 2 h and then treated with
2 µM PAB for 24 h. PAB decreased the genomic RNA levels of
both EV-D68 (28.32% of control; P< 0.001; Figure 6D) and EV-
A71 (59.87% of control; P < 0.001; Figure 6E). Furthermore,
PAB decreased the TCID50/ml value of both EV-D68 (80.31%
decrease; P < 0.01; Figure 6F) and EV-A71 (91.27% decrease;
P < 0.01; Figure 6G). These results confirm that G2/M arrest
inhibits both the EV-D68 and EV-A71 strains, which suggest
a common approach for therapeutic intervention that might
potentially target a broader range of enteroviruses.
DISCUSSION
Enterovirus 68 (EV-D68) usually causes mild to severe
respiratory illness, including runny nose, sneezing, cough,
body and muscle ache, wheezing, difficulty breathing, and in
the cases of some infants, children and teens, death. Although
EV-D68 was first identified in California in 1962, the number of
people in one breakout in 2014 with confirmed EV-D68 infection
was much greater than the number reported in previous years
(http://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html).
It is hard to predict whether EV-D68 will emerge again in future
outbreaks, but the value of resolving the pathogenic mechanism
of EV-D68 is obvious. In this study, we investigated the
pathogenic mechanism of EV-D68 to reveal the relationship
between virus infection and the host cell cycle.
To assess the possibility that the cell cycle status affects EV-
D68 viral replication, we first synchronized cells in G0/G1.
Our results demonstrate that G0/G1 arrest promotes EV-D68
replication and increases viral virulence without affecting virus
entry. We also assessed the effects of S phase and G2/M phase
synchronization on viral production. Our results suggest that
S phase synchronization does not affect viral entry, replication
or production compared to the control treatment, while G2/M
synchronization inhibits viral replication and decreases viral
virulence, but does not affect virus entry. These results indicate
that G0/G1 phase is most favorable for EV-D68 replication, that
S phase can support some viral production, and that G2/M phase
is inhibitory for host viral production.
Given that G0/G1 phase supports EV-D68 production,
it would be advantageous for the virus to manipulate
the host cell cycle to increase viral production. Indeed,
the EV-D68 Fermon strain displayed significant ability to
increase the percentage of cells in G0/G1 phase. The EV-
D68 Fermon strain was isolated in the United States in 1962
(Schieble et al., 1967), but currently circulating strains, including
EV-D68 US/MO/14-18947 and US/KY/14-18953, may be more
relevant to current human health. Therefore, we examined
whether these two currently circulating strains had similar
ability to manipulate the cell cycle. Our results confirmed
that the circulating EV-D68 strains manipulate the cell cycle
in a similar manner as does the Fermon strain, though the
current strains have higher virulence than Fermon. Therefore,
after more than 50 years’ evolution, EV-D68 still possesses the
ability to arrest cells at G0/G1 phase but EV-D68 virulence has
increased.
To pinpoint the cause for G0/G1 accumulation upon EV-D68
infection, we analyzed the transitions from G0/G1 into S and
from G2/M into G0/G1. After cell cycle release from G0/G1,
mock-infected cells entered S phase, while EV-D68-infected
cells still accumulated at G0/G1 phase, thus demonstrating that
EV-D68 infection prevents S phase entry from G0/G1 phase.
Furthermore, after G2/M synchronization, EV-D68 infection
promoted cell cycle transition from G2/M into G0/G1 phase.
Therefore, EV-D68 infection regulates G0/G1 cell cycle arrest
both by promoting G0/G1 phase entry and by inhibiting G0/G1
phase departure. To further analyze the mechanism of host
cell cycle manipulation by EV-D68, we assessed the expression
of cyclins and CDKs that are known to form complexes to
regulate cell cycle progression (Oosthuysen et al., 2015). For
example: cyclinD/CDK4 and cyclinD/CDK6 regulate G0/G1
progression (Massagué, 2004); cyclinE/CDK2 regulates S-phase
entry from G1 (Hinds et al., 1992); cyclinA/CDK2 regulates S-
phase progression by replacing cyclinE (Coverley et al., 2002; Yam
et al., 2002); and cyclinB1/CDK1 prevents cell cycle transition
from G2/M into G0/G1 (Yu et al., 2013; Adeyemi and Pintel,
2014). We demonstrated that cyclinD, CDK4, CDK6, cyclinE1
and CDK2 are down-regulated after EV-D68 infection, which
could explain the ability of EV-D68 to inhibit the transition
from G0/G1 to S phase. Furthermore, the expression of cyclinB1
and CDK1 was down-regulated after EV-D68 infection, which is
consistent with the ability of EV-D68 to promoting the transition
from G2/M to G0/G1. Therefore, expression of cell cycle-related
proteins further supports our results suggesting that EV-D68
induces G0/G1 arrest by regulating G0/G1 phase entry and exit.
We also analyzed whether the regulation of protein expression
occurred at the mRNA level and found that CDK2 and CDK1
were down-regulated by EV-D68, but that the other cell cycle
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proteins were not. This indicates that the regulation of cellular
factors related to the cell cycle by EV-D68 occurs partly at the
transcriptional level, but mostly occurs at the post-translational
level.
Viral non-structural proteins are often essential for viral
replication, so we also evaluated whether EV-D68 might exert
its host cell cycle regulatory function via its viral non-structural
proteins. Our results confirmed that the non-structural protein
3D increases the percentage of cells in G0/G1 phase by decreasing
the expression of the G0/G1 and S phase related-cell cycle
proteins cyclinD, CDK4 and cyclinE1, while 3C decreases the
percentage of cells in G2/M phase by decreasing the expression
of G2/M-related proteins CDK1 and cyclinB1. These findings
raise the possibility that the non-structural proteins 3D and 3C
may function coordinately in the context of an EV-D68 infection
to enhance the percentage of cells in G0/G1 and increase the
G0/G1 to G2/M ratio. It is noted that non-structural 3D protein
of EV-A71 mediates cell cycle arrest at S phase, while 3D of
EV-D68 mediated cell cycle at G0/G1, although until now the
detailed reason of the difference is not clear, it is speculated
that 290 of same amino acid sequence might bind with a same
target which is responsible for the function of cell cycle arrest,
while 172 of different amino acid sequence might bind other
different factors which is responsible for different ability of
cell cycle regulation, and this part will be investigated in the
future.
In the current study, we demonstrated that G0/G1 phase arrest
was required by EV-D68 production; however, in a previous
study, EV-A71 was shown to have the opposite effect (Yu et al.,
2015). This difference is surprising given that both EV-A71 and
EV-D68 belong to the Picornaviridae family. To further confirm
the different activities between the two viruses, we analyzed them
side by side, and our results confirm that G0/G1 synchronization
promotes EV-D68 viral production but inhibits EV-A71 viral
production. Therefore, EV-D68 an EV-A71 can both manipulate
the host cell cycle, but the process and outcomes of cell cycle
manipulation are entirely different, which could explain why
EV-D68 and EV-A71 have varying characteristics, such as the
epidemic region (Europe and Asia), the clinical symptoms, and
the epidemic size. Meanwhile, these results serve as a reminder
that different enteroviruses may require different therapeutic
treatments targeting a different set of host factors. Unfortunately,
the reason of the difference between them is not clear, but
it is speculated that some a host factor(s) generated or kept
high level in G0/G1 phase was required by EV-D68 production,
while EV-A71 required some a host factor(s) generated or kept
high level in S phase so that their non-structural 3D were
obligated by two viruses to regulate host cell cycle for their own
replication.
The main goal of analyzing the mechanism of EV-D68
pathogenesis was to identify new strategies for preventing
and treating the disease, so we did additional experiments
to further explore G2/M synchronization as an approach to
inhibit the replication of different EV-D68 strains. Our results
demonstrate that in addition to its effects on the EV-D68 Fermon
strain, G2/M synchronization by nocodazole inhibited the
replication and virulence of US/KY/14-18953 and US/MO/14-
18947. Additionally, PAB, which is another agent that can induce
G2/M arrest, also significantly inhibited the production of EV-
D68 and EV-A71. Because nocodazole also has been shown to
be effective in inhibiting the production of EV-A71 (Yu et al.,
2015), medicines that induce G2/M arrest might be considered
as a common approach for inhibiting different types of anti-
enterovirus infection, which provides a new direction for anti-
enterovirus drug development.
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